L, Y., S, L., Q, C., T, X., D, L., L, L., . . . L, T. (2022). EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma. Cell death and differentiation, 29(8), 1513. https://doi.org/10.1038/s41418-022-00939-8
Chicago Style (17th ed.) CitationL, Yuan, et al. "EBV Infection-induced GPX4 Promotes Chemoresistance and Tumor Progression in Nasopharyngeal Carcinoma." Cell Death and Differentiation 29, no. 8 (2022): 1513. https://doi.org/10.1038/s41418-022-00939-8.
MLA (9th ed.) CitationL, Yuan, et al. "EBV Infection-induced GPX4 Promotes Chemoresistance and Tumor Progression in Nasopharyngeal Carcinoma." Cell Death and Differentiation, vol. 29, no. 8, 2022, p. 1513, https://doi.org/10.1038/s41418-022-00939-8.